According to previous studies, CITED2 regulates the expression of several growth factors such as transforming growth factor-beta (TGFβ) [115], interleukin 11 (IL-11), interleukin 1 beta (IL-1β) [117] and HIF-1α [118] to promote breast cancer progression. Here, IL11 is linked to breast carcinoma.